Beijing, China

Lihua Hou

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2025

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: Lihua Hou: Innovator in Monoclonal Antibodies and mRNA Vaccines

Introduction

Lihua Hou is a prominent inventor based in Beijing, China, known for his significant contributions to the fields of monoclonal antibodies and mRNA vaccines. With a total of five patents to his name, Hou has made strides in developing innovative solutions for combating viral infections.

Latest Patents

One of his latest patents is the "Monoclonal antibody 2G1 for broad-spectrum neutralization of Ebola viruses and application thereof." This patent discloses a monoclonal antibody 2G1 that targets an Ebola glycoprotein GP2 subunit. The antibody demonstrates binding activity to various Ebola virus glycoproteins, including EBOV GP, BDBV GP, SUDV GP, and RESTV GP, showcasing its potential for neutralization.

Another notable patent is the "mRNA vaccine encoding fusion antigen against Mpox and severe acute respiratory syndrome coronavirus 2." This patent describes an mRNA molecule that encodes multiple antigens, including those for Mpox and SARS-CoV-2. The innovative aspect of this vaccine is its ability to induce robust neutralizing antibody responses and provide complete immune protection against lethal challenges, making it a promising candidate for future vaccine development.

Career Highlights

Lihua Hou has worked with esteemed institutions such as the Academy of Military Medical Science and the Institute of Biotechnology, both part of the PLA. His work in these organizations has allowed him to focus on groundbreaking research in immunology and vaccine development.

Collaborations

Throughout his career, Hou has collaborated with notable colleagues, including Wei Chen and Ling Fu, who have contributed to his research endeavors.

Conclusion

Lihua Hou's innovative work in monoclonal antibodies and mRNA vaccines positions him as a key figure in the fight against viral diseases. His patents reflect a commitment to advancing medical science and improving public health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…